Clinical Value of IL-2 in HIV-Infected Patients
Results from a small proof-of-concept study were encouraging in patients with moderately advanced HIV disease, but the findings are too outdated to have any clinical application.
Welcome to Journal Watch. The content you requested requires sign in with a username and password.
Sign In
Sign Up
Print subscribers
Activate your free online account for full access to all site content and features.
Other visitors
Subscribe for full access to all site content and features. ($99/year)
Purchase a site pass for full access to all articles. ($19/7 days)
Or, simply register for free access to email alerts, site features, and article archives. (FREE)